# Expert Opinion on Biological Therapy

**Type:** Journals  
**Canonical URL:** https://scholariq.org/journals/expert-opinion-on-biological-therapy/

## Facts

| Field | Value |
| --- | --- |
| Citations | 114,329 |
| h-index | 121 |
| Homepage | http://www.tandfonline.com/action/journalInformation?show=aimsScope&journalCode=iebt20 |
| Open Access | false |
| ISSN-L | 1471-2598 |
| ISSNs | 1471-2598,1744-7682 |
| OpenAlex ID | https://openalex.org/S57380513 |
| Publisher | Taylor & Francis |
| Works | 4,021 |

## Journal papers

- [Pembrolizumab for the treatment of non-small cell lung cancer](https://scholariq.org/papers/pembrolizumab-for-the-treatment-of-non-small-cell-lung-cancer-2/)
- [Efficacy of omalizumab in chronic spontaneous urticaria refractory to conventional therapy: analysis of 110 patients in real-life practice](https://scholariq.org/papers/efficacy-of-omalizumab-in-chronic-spontaneous-urticaria-refractory-to/)
- [Expert opinion on the use of biological therapy in non-infectious uveitis](https://scholariq.org/papers/expert-opinion-on-the-use-of-biological-therapy-in-non-infectious-uveitis/)
- [Teduglutide for treatment of adult patients with short bowel syndrome](https://scholariq.org/papers/teduglutide-for-treatment-of-adult-patients-with-short-bowel-syndrome/)
- [Ustekinumab treatment for moderate-to-severe plaque psoriasis: eight-year real-life experience](https://scholariq.org/papers/ustekinumab-treatment-for-moderate-to-severe-plaque-psoriasis-eight-year-real/)
- [Belimumab: a step forward in the treatment of systemic lupus erythematosus](https://scholariq.org/papers/belimumab-a-step-forward-in-the-treatment-of-systemic-lupus-erythematosus/)
- [Emerging role of monoclonal antibodies in the treatment of IgA nephropathy](https://scholariq.org/papers/emerging-role-of-monoclonal-antibodies-in-the-treatment-of-iga-nephropathy/)
- [The role of monoclonal antibodies in the treatment of lupus nephritis](https://scholariq.org/papers/the-role-of-monoclonal-antibodies-in-the-treatment-of-lupus-nephritis/)

## Journal top topics

Showing 8 of 25.

- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)
- [Virus-based gene therapy research](https://scholariq.org/topics/virus-based-gene-therapy-research/)
- [Monoclonal and Polyclonal Antibodies Research](https://scholariq.org/topics/monoclonal-and-polyclonal-antibodies-research/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [RNA Interference and Gene Delivery](https://scholariq.org/topics/rna-interference-and-gene-delivery/)
- [Biosimilars and Bioanalytical Methods](https://scholariq.org/topics/biosimilars-and-bioanalytical-methods/)
- [Mesenchymal stem cell research](https://scholariq.org/topics/mesenchymal-stem-cell-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.